Enzalutamide
FDA Approved: * May 14, 2021Pharm Company: * ACTAVIS LABS FL INC
Category: Cancer
Enzalutamide, sold under the brand name Xtandi, is a nonsteroidal antiandrogen (NSAA) medication which is used in the treatment of prostate cancer.[2][6] It is indicated for use in conjunction with castration in the treatment of metastatic castration-resistant prostate cancer (mCRPC),[2] nonmetastatic castration-resistant prostate cancer,[2] and metastatic castration-sensitive prostate cancer (mCSPC).[7] It is ta... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion
Related Brands
Drugs with the same active ingredientsPopular Topics
Enzalutamide for Joint Stiffness
Can I treat my bone/joint stiffness that I have recently started experiencing with Enzalutemide? ## Enzalutemide is an a...
1 REPLY